Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet

Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet · Investor's Business Daily
ALLISON GATLIN
2 min read

In This Article:

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.

Recommended Stories